Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
ANPCF
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q1.23
N/A
-0.02
vs -0.03
Q2.23
N/A
-0.05
vs -0.05
Q3.23
N/A
-0.02
vs -0.03
Q4.23
N/A
-0.03
vs -0.06
Q1.24
N/A
-0.02
vs -0.02
Q2.24
N/A
-0.02
vs -0.05
Q3.24
+100%
NA
vs -0.02
Q4.24
N/A
-0.01
vs -0.03
Q1.25
N/A
NA
vs -0.02
Q2.25
N/A
-0.04
vs -0.02
Sales Growth
YoY
Current
Estimates
Q1.23
+185%
598K vs 209.5K
Q2.23
+185%
1.2M vs 419K
Q3.23
+59%
495K vs 311K
Q4.23
-20%
495K vs 622K
Q1.24
-14%
517K vs 598K
Q2.24
-57%
517K vs 1.2M
Q3.24
+85%
914K vs 495K
Q4.24
+85%
914K vs 495K
Q1.25
-23%
398K vs 517K
Q2.25
-23%
398K vs 517K
Return on Equity
QoQ
Q1.23
-15%
-0.15
vs -0.31
Q2.23
-31%
-0.31
vs -0.15
Q3.23
-22%
-0.22
vs -0.31
Q4.23
-22%
-0.22
vs -0.22
Q1.24
-16%
-0.16
vs -0.22
Q2.24
-16%
-0.16
vs -0.16
Q3.24
-18%
-0.18
vs -0.16
Q4.24
-18%
-0.18
vs -0.18
Q1.25
-40%
-0.40
vs -0.18
Q2.25
-40%
-0.40
vs -0.40
Institutionnal Ownership
N/A
Q3.23
NA
NA
vs NA
NA
Q4.23
NA
NA
vs NA
NA
Q1.24
NA
NA
vs NA
NA
Q2.24
NA
NA
vs NA
NA
Q3.24
NA
NA
vs NA
NA
Q4.24
NA
NA
vs NA
NA
Q1.25
NA
NA
vs NA
NA
Q2.25
NA
NA
vs NA
NA
Q3.25
NA
NA
vs NA
NA
Q4.25
NA
NA
vs NA
NA
proactiveinvestors.co.uk
3 hours ago
proactiveinvestors.co.uk
4 hours ago
proactiveinvestors.co.uk
4 hours ago
proactiveinvestors.co.uk
6 hours ago
proactiveinvestors.co.uk
8 hours ago
Relative Strength
ANPCF
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD multiplex analysis system for routine and focused multiplex analysis of DNA, RNA or protein biomarkers. The company was founded in 1994 and is based in Guildford, the United Kingdom.
OTC
Unprofitable
Unprofitable
After-hours 0.05$
0.00 (0.00%)
Relative Strenght
Volume Buzz
4487%
Earning Acce
No
Dist 52w H.
70%Quote Panel
Key Metrics
Forecast
115%2026-Revenue
8%2026-EPS
-115%2026-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
N/A(N/A)
Number of analyst
N/A
Last analyst upgrade/downgrade
No Data Available
Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How ANPCF compares to sector?